Skip to main content
EssilorLuxottica logo

EssilorLuxottica — Investor Relations & Filings

Ticker · EL ISIN · FR0014007HJ5 LEI · 549300M3VH1A3ER1TB49 PA Manufacturing
Filings indexed 1,139 across all filing types
Latest filing 2017-04-07 Proxy Solicitation & In…
Country FR France
Listing PA EL

About EssilorLuxottica

https://www.essilorluxottica.com/

EssilorLuxottica is a global leader in the design, manufacture, and distribution of ophthalmic lenses, prescription frames, and sunglasses. The company operates a vertically integrated business model, managing a comprehensive portfolio of proprietary and licensed eyewear and vision care brands. Its activities encompass the production of advanced vision care products, including lenses and optical instruments, as well as a wide range of eyewear. EssilorLuxottica distributes its products through a global network of wholesale and retail channels, serving consumers with solutions for their vision needs and personal style.

Recent filings

Filing Released Lang Actions
PDF version of the news release
Proxy Solicitation & Information Statement Classification · 98% confidence The document explicitly discusses the 'Procedures for Requesting or Viewing Proxy Information for the Combined (Ordinary and Extraordinary) Annual Meeting' scheduled for May 11, 2017. It details where and how shareholders can consult proxy documents and information related to the meeting's agenda and resolutions. This content is directly related to soliciting shareholder votes and providing necessary pre-meeting information, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it mentions the Annual Meeting, the focus is on the procedural documents for voting, not the final voting results (DVA) or the meeting presentation itself (AGM-R).
2017-04-07 English
PDF version of the news release
Proxy Solicitation & Information Statement Classification · 98% confidence The document explicitly discusses the 'Procedures for Requesting or Viewing Proxy Information for the Special Meeting of Holders of Shares with Double Voting Rights' scheduled for May 11, 2017. It details where and how shareholders can consult proxy documents and information related to the meeting agenda and resolutions. This content is directly related to soliciting shareholder votes and providing necessary pre-meeting information, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it mentions the preliminary notice of meeting, the core focus is on the procedures for accessing proxy materials for the upcoming vote.
2017-04-07 English
PDF version of the news release
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'publication of an information document' concerning a major corporate action: the issuance of Essilor shares in exchange for the contribution in kind of Luxottica shares (a merger/acquisition component). It details the registration of this document (Document E) with the AMF and mentions that the transaction will be submitted for approval at the General Shareholders' Meeting. Since the core subject is a significant transaction involving share capital changes (exchange ratio, new shares issued) related to a merger/takeover activity, the most fitting primary category is M&A Activity (TAR). However, the document is primarily focused on the capital structure change resulting from the transaction (issuance of new shares in exchange for assets/shares). Given the detailed description of the share issuance, capital increase, and admission to trading, it strongly relates to Capital/Financing Update (CAP) or M&A Activity (TAR). Since the transaction is a 'contribution in kind' in exchange for shares, which is a form of takeover/merger, TAR is highly relevant. Furthermore, the document details the issuance of new shares (SHA). Because the document is an announcement about the registration of the information document related to the exchange of shares for a corporate combination, it fits best under M&A Activity (TAR) or Share Issue/Capital Change (SHA). Given the context of the 'contemplated combination between Essilor and Luxottica,' TAR is the most specific fit for the overall event. If it were purely about a buyback or a standard rights issue, SHA would be better. Since it's an exchange for a major corporate combination, TAR is selected.
2017-04-07 English
Version pdf du communiqué
M&A Activity Classification · 95% confidence The document is an announcement from Essilor regarding the 'mise à disposition' (making available) of an information document ('document d'information') related to a capital increase via the contribution in kind of Luxottica shares. This process involves the issuance of new Essilor shares as consideration for the Luxottica shares, which is a significant corporate action related to capital structure and financing (the merger/acquisition process). The text explicitly mentions the registration of the 'Document E' with the AMF (Autorité des Marchés Financiers) and details the exchange ratio and the upcoming shareholder vote. Since the core subject is the issuance of new shares as part of a major transaction (the Essilor/Luxottica combination), and it involves a capital increase ('augmentation de capital'), the most fitting category is Capital/Financing Update (CAP). Although it relates to a merger (TAR), the immediate focus of this specific filing is the share issuance mechanism and the associated documentation.
2017-04-07 French
Version pdf du communiqué
Share Issue/Capital Change Classification · 95% confidence The document explicitly states it provides the 'Nombre total de droits de vote et d'actions composant le capital social au 31 mars 2017' (Total number of voting rights and shares comprising the share capital as of March 31, 2017). It cites French regulatory articles (Code de Commerce and AMF General Regulation) and presents a table detailing the total number of shares and voting rights. This type of mandatory disclosure regarding the total share capital and voting rights structure is a specific regulatory filing, often related to capital structure updates or mandatory periodic disclosures. Given the options, it most closely aligns with a disclosure about the capital structure or a general regulatory announcement. Since it is a specific, mandatory disclosure about the number of shares and voting rights, it fits best under 'Share Issue/Capital Change' (SHA) if it reflects a change, or 'Regulatory Filings' (RNS) if it's a standard periodic update not covered elsewhere. However, since it details the composition of the capital and voting rights, which is a fundamental aspect of share structure, SHA is a strong candidate. If it were a general announcement of a dividend or a buyback, other codes would apply. Because it is a formal statement of the total capital structure as of a specific date, it relates directly to the company's share capital base. Given the options, SHA (Share Issue/Capital Change) covers changes or updates to the capital structure, which this disclosure pertains to, even if it's just a periodic count. Alternatively, RNS is a fallback. Given the precise nature of the data (total shares/votes), SHA is the most specific fit among the choices for capital structure reporting.
2017-04-05 French
PDF version of the news release
Share Issue/Capital Change Classification · 90% confidence The document explicitly states its purpose in the title: "Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2017". It provides specific figures for shares outstanding and voting rights, referencing French commercial code and AMF regulations. This type of disclosure, focusing on the total number of shares and voting rights, is a specific regulatory filing related to capital structure and ownership disclosure, often required periodically. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It most closely aligns with filings related to capital structure changes or major shareholding notifications, but the specific nature of disclosing total voting rights makes it a specialized disclosure. Given the options, it is a specific regulatory disclosure about the capital base. Since there isn't a perfect fit for 'Share Capital Disclosure', I must evaluate the closest options. It is not a Director's Dealing (DIRS), but it is related to ownership structure. It is not a general M&A (TAR) or a general Share Issue (SHA). However, the disclosure of total voting rights and shares outstanding is a fundamental piece of information often required alongside major ownership changes or capital events. Given the context of French regulation (AMF), this is a mandatory periodic disclosure. Since it details the total number of shares and voting rights, it is a specific type of capital/share structure announcement. 'SHA' (Share Issue/Capital Change) is the closest category that covers fundamental changes or disclosures about the share base, although this is a disclosure *about* the existing base rather than an *announcement* of a new issue. If this were a general regulatory announcement not fitting elsewhere, RNS would be used. However, because it is a precise disclosure of the total share count and voting rights, it is a specific capital structure report. I will classify it as 'SHA' as it pertains directly to the share capital structure, which is a core component of that category, even if it's a disclosure rather than an issuance announcement.
2017-04-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.